CME Group Inc. (CME)
NASDAQ: CME · Real-Time Price · USD
259.83
+1.00 (0.39%)
At close: Sep 16, 2025, 4:00 PM EDT
260.00
+0.17 (0.07%)
After-hours: Sep 16, 2025, 7:57 PM EDT
CME Group Stock Forecast
Stock Price Forecast
The 15 analysts that cover CME Group stock have a consensus rating of "Hold" and an average price target of $260.6, which forecasts a 0.30% increase in the stock price over the next year. The lowest target is $198 and the highest is $304.
Price Target: $260.6 (+0.30%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for CME Group stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 0 | 0 | 0 |
| Buy | 5 | 5 | 5 | 4 | 4 | 4 |
| Hold | 7 | 7 | 7 | 8 | 8 | 8 |
| Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Strong Sell | 2 | 2 | 1 | 1 | 1 | 1 |
| Total | 17 | 17 | 16 | 15 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Maintains $305 → $285 | Hold | Maintains | $305 → $285 | +9.69% | Sep 8, 2025 |
| UBS | UBS | Strong Buy → Hold Downgrades $305 | Strong Buy → Hold | Downgrades | $305 | +17.38% | Jul 24, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $300 → $303 | Buy | Maintains | $300 → $303 | +16.61% | Jul 24, 2025 |
| Barclays | Barclays | Hold Maintains $299 → $298 | Hold | Maintains | $299 → $298 | +14.69% | Jul 24, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $283 → $296 | Buy | Maintains | $283 → $296 | +13.92% | Jul 15, 2025 |
Financial Forecast
Revenue This Year
6.58B
from 6.12B
Increased by 7.48%
Revenue Next Year
6.86B
from 6.58B
Increased by 4.30%
EPS This Year
11.28
from 9.67
Increased by 16.66%
EPS Next Year
11.72
from 11.28
Increased by 3.91%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 7.0B | 7.6B | |||
| Avg | 6.6B | 6.9B | |||
| Low | 6.3B | 6.3B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 15.1% | 16.0% | |||
| Avg | 7.5% | 4.3% | |||
| Low | 2.6% | -3.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 12.11 | 12.75 | |||
| Avg | 11.28 | 11.72 | |||
| Low | 10.61 | 10.74 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 25.2% | 13.0% | |||
| Avg | 16.7% | 3.9% | |||
| Low | 9.8% | -4.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.